Emerald Health Therapeutics Inc TBQBF

RE:Emerald Health @ Watch-Zone

[FelixFun]

year-over-year revenue increased by 15%
Emerald Health Therapeutics announced today the financial results for the three and six months ended June 30, 2018. Quarter-over-quarter revenue declined from $373,218 to $284,262. However, year-over-year revenue increased by 15%, rising from $245,708 during the same period in the previous year. Net loss for the company increased from $5.04 million in the previous quarter to $5.6 million. Despite the increased loss, Emerald Health CEO Chris Wagner was nonetheless pleased with the results. “I am proud of the success we’ve had scaling our business so far this year,” said Wagner. “Since the start of the second quarter, we acquired and began cultivating cannabis at our Quebec-based licensed producer Agro-Biotech, substantially increased our licensed cannabis production area at our Pure Sunfarms joint venture to roughly 420,000 square feet, and obtained from Health Canada Pure Sunfarms’ sales license.”